The latest announcement is out from GlaxoSmithKline ( (GB:GSK) ).

The global Zoonotic Disease Treatment Market, valued at USD 46.4 billion in 2025, is projected to grow to USD 82.3 billion by ...

August 19, 2025) – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) (“PreveCeutical” or the “Company“), a health sciences company that develops innovative options for preventive and ...

There is no cure for congenital erythropoietic porphyria, but after years of work and patient collaboration, a potential drug ...

GSK PLC closed 14.28% short of its 52-week high of £16.79, which the company reached on September 9th.

Many parents admonish their children to stop playing in sand, but sand has been a family business for six generations of the Clifford W. Estes Company. The company’s longtime motto is “color ...

Mumbai: In a major relief for Thermo Fisher Scientific India Pvt. Ltd., the Income Tax Appellate Tribunal (ITAT), Mumbai "H" ...

Eli Lilly will raise UK list prices for its Mounjaro weight-loss jab by as much as 170% from September after Donald Trump ...

GSK Egypt posted non-consolidated net profits after tax of EGP 71.33 million in H1-25, an annual drop from EGP 99.54 million.

Arab Finance: GlaxoSmithKline Egypt (GSK–Egypt) logged consolidated net profits for controlling interest of EGP 65.060 ...

The most recent analyst rating on (GB:GSK) stock is a Buy with a £2610.00 price target. To see the full list of analyst forecasts on GlaxoSmithKline stock, see the GB:GSK Stock Forecast page.

Royalty Pharma plc (Nasdaq: RPRX) today announced that Henry Fernandez, its Lead Independent Director, has stepped down from its Board of Directors, effective August 13, 2025. Mr. Fernandez joined the ...